Target intelligence / Profile preview

Mesangial matrix and its cytokines

Molecular classification
Extracellular matrix, Cytokine, Growth factor
01

Overview

The mesangial matrix is a specialized extracellular matrix (ECM) located within the renal glomerulus that provides essential structural support to the capillary loops and modulates the glomerular filtration surface area. It is primarily composed of proteins such as Type IV and V collagens, laminin, and fibronectin, which are synthesized and maintained by resident mesangial cells. In addition to its structural role, the matrix serves as a reservoir and signaling hub for various cytokines and growth factors, including Transforming Growth Factor-beta (TGF-beta), Platelet-Derived Growth Factor (PDGF), and tumor necrosis factor-alpha (TNF-alpha). Under pathological conditions like diabetic nephropathy or lupus nephritis, these cytokines drive an imbalance in matrix homeostasis, leading to excessive ECM deposition and mesangial expansion. This expansion eventually results in glomerulosclerosis and progressive loss of kidney function. Therapeutic interventions often target specific signaling components within this environment, such as TGF-beta or PDGF receptors, to inhibit the profibrotic and inflammatory cascades that characterize chronic kidney disease.

Other names
Glomerular mesangiumMesangial extracellular matrixMesangial signaling environmentRenal mesangial matrix
02

Mechanism of action

Mechanisms include the inhibition of profibrotic signaling (TGF-beta/Smad pathway), blockade of mitogenic growth factor receptors (PDGFR), and reduction of inflammatory cytokine production to prevent pathological extracellular matrix accumulation and mesangial cell hypertrophy.

03

Biological functions

Glomerular filtrationStructural supportTissue remodelingSignal transductionImmune responseCell proliferation
04

Disease associations

Diabetic nephropathyGlomerulonephritisChronic kidney diseaseLupus nephritisIgA nephropathyGlomerulosclerosis
05

Safety considerations

Impaired wound healing due to TGF-beta or PDGF inhibitionSystemic immunosuppressionCardiovascular side effectsPotential for acute kidney injury if glomerular hemodynamics are severely altered
06

Interacting drugs

Fresolimumab

7 more in the full profile.

07

Biomarkers

Urinary TGF-beta 1Urinary Type IV CollagenUrinary Albumin-to-Creatinine Ratio (UACR)Serum FibronectinMesangial expansion (histological)

Beyond the preview

Go deeper on Mesangial matrix and its cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesangial matrix and its cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call